发明申请
US20120028992A1 Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals 审中-公开
用于终止心律失常急性发作,恢复窦性心律,预防心律失常复发和/或维持哺乳动物正常窦性心律的药物组合物

  • 专利标题: Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
  • 专利标题(中): 用于终止心律失常急性发作,恢复窦性心律,预防心律失常复发和/或维持哺乳动物正常窦性心律的药物组合物
  • 申请号: US12805460
    申请日: 2010-08-02
  • 公开(公告)号: US20120028992A1
    公开(公告)日: 2012-02-02
  • 发明人: Arthur M. Brown
  • 申请人: Arthur M. Brown
  • 主分类号: A61K31/495
  • IPC分类号: A61K31/495 A61P9/06
Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
摘要:
Disclosed are pharmaceutical compositions for and methods of preventing or treating acute and/or chronic cardiac arrhythmias in a mammal, including terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm, which contain a combination of 1-[2-[(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine.
信息查询
0/0